Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Non-pathogenic E. coli displaying decoy-resistant IL18 mutein boosts anti-tumor and CAR NK cell responses

4 Oct 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Research and Treatments
Share to CAR-T cell therapy research
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39367093
DOI: 10.1038/s41587-024-02418-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Non-pathogenic E. coli displaying decoy-resistant IL18 mutein boosts anti-tumor and CAR NK cell responsesPMID 39367093Read ↗

Nonpathogenic E. coli engineered to surface display cytokines as a new platform for immunotherapySemantic proximity Read ↗

<i>Enterococcus</i> peptidoglycan remodeling promotes immune checkpoint inhibitor therapySemantic proximity Read ↗

A Nanovial-Based Platform for Functional Discovery of Antigen-Reactive TCRs from Unconventional T CellsSemantic proximity Read ↗

Rational design of immune gene therapy combinations via <i>in vivo</i> CRISPR activation screen of tumor microenvironment modulatorsSemantic proximity Read ↗

Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble ICAM-1 in regulating antigen-specific tumor cell killing by cytotoxic T cellsSemantic proximity Read ↗

Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble ICAM-1 in regulating antigen specific tumor cell killing by cytotoxic T cellsSemantic proximity Read ↗

Interleukin-18 (IL-18) engineered for half-life extension and resistance to IL-18 binding protein (IL-18BP) to enhance anti-cancer therapeutic potentialSemantic proximity Read ↗

Engineering human Mucosal Associated Invariant T (MAIT) cells with chimeric antigen receptors for cancer immunotherapy <sup>1</sup>Semantic proximity Read ↗

Virus-free CRISPR knock-in of a chimeric antigen receptor into <i>KLRC1</i> generates potent GD2-specific natural killer cellsSemantic proximity Read ↗

MR1-Restricted T Cells Are Unprecedented Cancer Fighters.Semantic proximity Read ↗

<i>Listeria monocytogenes</i> personalized cancer vaccines drive therapeutic immune responses to cancer derived neoantigensSemantic proximity Read ↗

Immunomics: discovering new targets for vaccines and therapeuticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.